Literature DB >> 16603620

Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.

Helen Findlow1, Jo Southern, Lesley Mabey, Paul Balmer, Robert S Heyderman, Cressida Auckland, Rhonwen Morris, Elizabeth Miller, Ray Borrow.   

Abstract

Changes in the immunoglobulin G1 (IgG1)/IgG2 ratio following vaccination can indicate the activation of cellular control mechanisms typical of a T-cell-dependent response. We examined IgG subclass ratios in 17 healthy adults (26 to 55 years of age) before and 4 to 6 weeks following immunization with a quadrivalent meningococcal-polysaccharide diphtheria toxoid conjugate vaccine against serogroups A, C, Y, and W135. Serologic responses were determined by serum bactericidal antibody assay and serogroup-specific IgG, IgG1, and IgG2 enzyme-linked immunosorbent assay. Prevaccination serogroup A-specific IgG1/IgG2 ratios were <1 for all subjects and differed by subject for C, Y, and W-135. Postvaccination, significant increases in IgG, IgG1, and IgG2, were observed for all serogroups. Serogroup-specific IgG1/IgG2 ratios increased for group A (14/17 subjects, 88%), decreased in more than half of subjects for groups C (9/17, 53%) and W135 (12/17, 71%) and decreased for serogroup Y (16/17, 94%). IgG1/IgG2 ratios differed between individual vaccinees and were similar to the responses of adults who received pneumococcal conjugate vaccines or a monovalent C conjugate vaccine. Further studies on IgG subclasses following meningococcal polysaccharide and conjugate vaccination are needed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603620      PMCID: PMC1459635          DOI: 10.1128/CVI.13.4.507-510.2006

Source DB:  PubMed          Journal:  Clin Vaccine Immunol        ISSN: 1556-679X


  20 in total

1.  Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults.

Authors:  David Goldblatt; Ray Borrow; Elizabeth Miller
Journal:  J Infect Dis       Date:  2002-01-10       Impact factor: 5.226

2.  Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan.

Authors:  Zhiming Huo; Ruchi Sinha; Edel A McNeela; Ray Borrow; Rafaela Giemza; Catherine Cosgrove; Paul T Heath; Kingston H G Mills; Rino Rappuoli; George E Griffin; David J M Lewis
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Isotype concentrations of human antibodies to group A meningococcal polysaccharide.

Authors:  N Rautonen; J Pelkonen; S Sipinen; H Käyhty; O Mäkelä
Journal:  J Immunol       Date:  1986-10-15       Impact factor: 5.422

4.  Response to oligosaccharide-protein conjugate vaccine against Hemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine.

Authors:  R A Insel; P W Anderson
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

5.  Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.

Authors:  J B Robbins; L Myerowitz; J K Whisnant; M Argaman; R Schneerson; Z T Handzel; E C Gotschlich
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

6.  IgG subclass levels in infancy and childhood.

Authors:  V A Oxelius
Journal:  Acta Paediatr Scand       Date:  1979-01

7.  Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy.

Authors:  J MacLennan; S Obaro; J Deeks; D Lake; C Elie; G Carlone; E R Moxon; B Greenwood
Journal:  J Infect Dis       Date:  2000-11-15       Impact factor: 5.226

8.  Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults.

Authors:  James D Campbell; Robert Edelman; James C King; Thomas Papa; Robert Ryall; Margaret B Rennels
Journal:  J Infect Dis       Date:  2002-11-14       Impact factor: 5.226

9.  Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.

Authors:  Nick Andrews; Ray Borrow; Elizabeth Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09

10.  Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera.

Authors:  Helen Joseph; Paul Balmer; Mike Bybel; Thomas Papa; Robert Ryall; Ray Borrow
Journal:  Clin Diagn Lab Immunol       Date:  2004-01
View more
  15 in total

1.  Impaired antibody response to conjugated meningococcal serogroup C vaccine in asplenic patients.

Authors:  A Meerveld-Eggink; O de Weerdt; R M de Voer; G A M Berbers; H van Velzen-Blad; B J Vlaminckx; D H Biesma; G T Rijkers
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-12-24       Impact factor: 3.267

2.  Development of a fluorescent-bead-based multiplex immunoassay to determine immunoglobulin G subclass responses to Neisseria meningitidis serogroup A and C polysaccharides.

Authors:  Richarda M de Voer; Fiona R M van der Klis; Carla W A M Engels; Ger T Rijkers; Elisabeth A Sanders; Guy A M Berbers
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

3.  Genetic variants in toll-like receptor 2 (TLR2), TLR4, TLR9, and FCγ receptor II are associated with antibody response to quadrivalent meningococcal conjugate vaccine in HIV-infected youth.

Authors:  Stephen A Spector; Min Qin; Jorge Lujan-Zilbermann; Kumud K Singh; Meredith G Warshaw; Paige L Williams; Patrick Jean-Philippe; Terence Fenton; George K Siberry
Journal:  Clin Vaccine Immunol       Date:  2013-04-17

Review 4.  Meningococcal vaccination in pregnancy.

Authors:  Bahaa Abu Raya; Manish Sadarangani
Journal:  Hum Vaccin Immunother       Date:  2018-03-21       Impact factor: 3.452

5.  Comprehensive proteomic profiling of outer membrane vesicles from Campylobacter jejuni.

Authors:  Kyoung-Soon Jang; Michael J Sweredoski; Robert L J Graham; Sonja Hess; William M Clemons
Journal:  J Proteomics       Date:  2013-12-29       Impact factor: 4.044

6.  Age-related immunity to meningococcal serogroup C vaccination: an increase in the persistence of IgG2 correlates with a decrease in the avidity of IgG.

Authors:  Richarda M de Voer; Fiona R M van der Klis; Rutger M Schepp; Ger T Rijkers; Elisabeth A M Sanders; Guy A M Berbers
Journal:  PLoS One       Date:  2011-08-24       Impact factor: 3.240

7.  Molecular signatures of antibody responses derived from a systems biology study of five human vaccines.

Authors:  Shuzhao Li; Nadine Rouphael; Sai Duraisingham; Sandra Romero-Steiner; Scott Presnell; Carl Davis; Daniel S Schmidt; Scott E Johnson; Andrea Milton; Gowrisankar Rajam; Sudhir Kasturi; George M Carlone; Charlie Quinn; Damien Chaussabel; A Karolina Palucka; Mark J Mulligan; Rafi Ahmed; David S Stephens; Helder I Nakaya; Bali Pulendran
Journal:  Nat Immunol       Date:  2013-12-15       Impact factor: 25.606

8.  Immunogenic recombinant Burkholderia pseudomallei MprA serine protease elicits protective immunity in mice.

Authors:  Chui-Yoke Chin; Swee-Chen Tan; Sheila Nathan
Journal:  Front Cell Infect Microbiol       Date:  2012-06-15       Impact factor: 5.293

9.  Neisseria meningitidis Group A IgG1 and IgG2 Subclass Immune Response in African Children Aged 12-23 Months Following Meningococcal Vaccination.

Authors:  Daniel Holme; Helen Findlow; Samba O Sow; Olubukola T Idoko; Marie-Pierre Preziosi; George Carlone; Brian D Plikaytis; Ray Borrow
Journal:  Clin Infect Dis       Date:  2015-11-15       Impact factor: 9.079

10.  Neonatal infections in Saudi Arabia: association with C-reactive protein, CRP -286 (C>T>A) gene polymorphism and IgG antibodies.

Authors:  Amre Nasr; Gamal Allam; Ali Al-Zahrani; Adnan Alsulaimani
Journal:  BMC Immunol       Date:  2013-08-13       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.